Author： Papanas Nikolaos Maltezos Efstratios
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.33, Iss.6, 2010-06, pp. : 455-461
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Becaplermin good value for diabetic foot ulcers
Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. :
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :
Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures
Drug Safety, Vol. 28, Iss. 10, 2005-01 ,pp. :
Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis
By Mikuls T.R.
Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. :